DDAVP Injection 4 mcg/mL contains as active substance, desmopressin acetate, a synthetic analogue of the natural hormone arginine vasopressin. One mL (4 mcg) of DDAVP (desmopressin acetate)...
label - Food and Drug Administration
DDAVP Injection is indicated as antidiuretic replacement therapy in the management of central (cranial) diabetes insipidus and for the management of the temporary polyuria and polydipsia...
Recommended starting dose is 0.05 mg desmopressin acetate (half of the 0.1 mg Desmopressin Acetate Tablet) orally two times a day. Titrate the daily dosage as needed. The usual dosage range...
DDAVP Injection 4 mcg/mL contains as active substance, desmopressin acetate, a synthetic analogue of the natural hormone arginine vasopressin. One mL (4 mcg) of DDAVP (desmopressin acetate) solution has an antidiuretic activity of about 16 IU; 1 mcg of DDAVP is equivalent to 4 IU.
Desmopressin Acetate Injection, USP - Pfizer
Desmopressin Acetate Injection, USP 4 mcg/mL is provided as a sterile, aqueous solution for intravenous or subcutaneous use. Each mL contains desmopressin acetate, 4 mcg (equivalent to 0.004 mg of desmopressin) and sodium chloride, 9 mg. May contain hydrochloric acid for pH adjustment. The pH range is 3.5 to 6.0.
Desmopressin: Package Insert / Prescribing Info - Drugs.com
2024年12月16日 · Desmopressin package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Central Diabetes Insipidus: Desmopressin Acetate Tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. Desmopressin acetate is ineffective for the treatment of
DESMOPRESSIN ACETATE injection, solution - DailyMed
2024年1月15日 · Desmopressin Acetate Injection, USP (desmopressin acetate) is a synthetic vasopressin analog for intravenous or subcutaneous use. It is chemically defined as follows: Mol. Wt. 1129.27 - Empirical ...
DESMOPRESSIN ACETATE (UBI Pharma Inc.): FDA Package Insert
2024年9月27日 · Desmopressin Acetate Injection USP is indicated as antidiuretic replacement therapy in the management of central (cranial) diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region.
When switching from the desmopressin acetate injection to DDAVP Nasal Spray, administer 10 times the amount of desmopressin acetate, rounding down to the nearest 10 mcg.